Galapagos NV

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date 12 oct 2020 - 15:15

Statutory name Galapagos NV

Title PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS

Previous result

Next result

Related downloads

202010120000000006_FASE 2B3-STUDIE TOONT WERKZAAMHEID VAN FILGOTINIB VOOR AANZET EN ONDERHOUD VAN REMISSIE BIJ MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA.pdf (opens in a new window)

202010120000000006_PHASE 2B3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS.pdf (opens in a new window)

Date last update: 18 August 2025